FRESENIUS SE+CO.KGAA O.N.
FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
FRE
|
2024-04-16 7:56:18 AM
|
Chg.
-0.040
|
Volume |
Bid7:56:18 AM |
Ask7:56:18 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
25.150EUR
|
-0.16%
|
-
Turnover: - |
25.150Bid Size: - |
25.360Ask Size: - |
14.27 bill.EUR |
- |
- |
Business description
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
Management board & Supervisory board
| CEO |
| Michael Sen |
| Management board |
| Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser |
| Supervisory board |
| Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel |
Company data
| Name: |
Fresenius SE & Co. KGaA |
| Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Phone: |
+49-6172-608-0 |
| Fax: |
- |
| E-mail: |
pr-fre@fresenius.com
|
| Internet: |
www.fresenius.de |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
56.49% |
| IPO date: |
1986-12-18 |
Investor relations
| Name: |
Markus Georgi |
| IR phone: |
+49-6172-608-2485 |
| IR Fax: |
+49-6172-608-2488 |
| IR e-mail: |
ir-fre@fresenius.com
|
Company calendar
|
CW 19 | 2024-05-08
Interim Report 1st Quarter/3 Months
|
|
CW 20 | 2024-05-17
General Shareholder Meeting
|
|
CW 31 | 2024-07-31
Interim Report 2nd Quarter/6 Months
|
|
CW 45 | 2024-11-06
Interim Report 3rd Quarter/9 Months
|
